Ecaterina Dumbrava

Clinical trials

• Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)

  Principal investigator · Active not recruiting · Phase 1

  M.D. Anderson Cancer Center

  2025–2030
• Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

  Principal investigator · Recruiting · Phase 1

  M.D. Anderson Cancer Center

  2024–2029
• Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

  Principal investigator · Recruiting · Phase 1

  M.D. Anderson Cancer Center

  2023–2040
• A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

  Principal investigator · Recruiting · Phase 2

  M.D. Anderson Cancer Center

  2023–2029